GE HealthCare secures CE mark for MINItrace Magni cyclotron
GE HealthCare has secured CE Mark certification for its MINItrace Magni cyclotron and broadened its PETtrace Solid Target Platform to…
All articles by Salong Debbarma
Salong Debbarma
-
-
Merz concludes enrolment in Phase III Xeomin trials for migraine
Merz Therapeutics has concluded patient enrolment in MINT-C and MINT-E, two global Phase III clinical trials assessing Xeomin (incobotulinumtoxinA) for…
-
Transcripta Bio, Mayo Clinic join force on ALS therapies
Transcripta Bio has entered into a research collaboration and licensing agreement with Mayo Clinic to identify potential treatments and therapeutic…
-
FDA approves Stryker’s Sonopet 3 surgical platform
The US Food and Drug Administration (FDA) has granted 510(k) clearance to Stryker for Sonopet 3, the medical technology company's…
-
Alentis and PinotBio partner to develop claudin-1 oncology ADCs
Alentis Therapeutics and PinotBio have entered into a research collaboration and licensing agreement to develop claudin-1-targeting antibody-drug conjugates (ADCs) for…
-
Pilatus doses first patient in Phase I PLT012 trial for HCC
Pilatus Biosciences has dosed the first patient in Hong Kong, as part of an ongoing Phase I clinical trial assessing…
-
Butterfly Medical secures EU MDR certification for BPH implant
Israel-based Butterfly Medical has secured European Union Medical Device Regulation (EU MDR 2017/745) certification for its Butterfly Prostatic Retraction Device.…
-
Dosing completed in Calluna Pharma’s Phase II AURORA trial
Calluna Pharma has completed patient dosing in its Phase II AURORA trial of CAL101 to treat idiopathic pulmonary fibrosis (IPF).…
-
Pfizer partners with Enodia Therapeutics in $500m drug deal
Pfizer and Enodia Therapeutics have announced a research collaboration and licensing deal potentially worth over $500m to discover and develop…
-
Southern Research secures NIH funding for drug testing hub
Southern Research has secured an $8m grant from the US National Institutes of Health (NIH) to establish a national shared-use…